Literature DB >> 1820196

Structures and functional roles of the sugar chains of human erythropoietins.

M Takeuchi1, A Kobata.   

Abstract

Erythropoietin (EPO) is a haemopoietic hormone specific to cells of erythroid lineage. EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells. Human EPO is characterized by its large carbohydrate chains, which occupy close to 40% of its total mass. These sugar moieties were thought to be important for the biological activity of EPO, but detailed studies were not performed until the structures were elucidated. The variety of roles for the sugar chains were then immediately found once the structures were known. EPO is an excellent model for investigating the roles of sugar chains on glycoproteins, since its gene and its multiple glycoforms are available, as well as sensitive bioassays for testing. In this review, we will first summarize the known sugar chain structures of EPO from different host cells, and then discuss the host-cell dependent and peptide structure-dependent glycosylation of glycoproteins. We will then address how one investigates the roles of sugar chains of glycoproteins, show several examples of such investigations, and discuss the functional roles of HuEPO's sugar chains in its biosynthesis and secretion, its in vitro and in vivo biological activities, and its half-life in blood circulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1820196     DOI: 10.1093/glycob/1.4.337

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  30 in total

1.  Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Authors:  L Monaco; A Marc; A Eon-Duval; G Acerbis; G Distefano; D Lamotte; J M Engasser; M Soria; N Jenkins
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Roles of silkworm endoplasmic reticulum chaperones in the secretion of recombinant proteins expressed by baculovirus system.

Authors:  Saki Imai; Takahiro Kusakabe; Jian Xu; Zhiqing Li; Shintaro Shirai; Hiroaki Mon; Daisuke Morokuma; Jae Man Lee
Journal:  Mol Cell Biochem       Date:  2015-08-12       Impact factor: 3.396

3.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

Review 4.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

5.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

Review 6.  Emerging erythropoiesis-stimulating agents.

Authors:  Robert N Foley
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

7.  Cloning and expression of a porcine UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase.

Authors:  A Yoshida; T Hara; H Ikenaga; M Takeuchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

8.  N-Glycosylation engineering of tobacco plants to produce asialoerythropoietin.

Authors:  Farooqahmed S Kittur; Chiu-Yueh Hung; Diane E Darlington; David C Sane; Jiahua Xie
Journal:  Plant Cell Rep       Date:  2012-02-28       Impact factor: 4.570

9.  Genome-scale metabolic reconstruction and in silico analysis of methylotrophic yeast Pichia pastoris for strain improvement.

Authors:  Bevan Ks Chung; Suresh Selvarasu; Camattari Andrea; Jimyoung Ryu; Hyeokweon Lee; Jungoh Ahn; Hongweon Lee; Dong-Yup Lee
Journal:  Microb Cell Fact       Date:  2010-07-01       Impact factor: 5.328

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.